Viral Infections and TreatmentUpdates the current body of knowledge on the transmission, diagnosis, and treatment of viral diseases. Offers new antiviral agents and diagnostic tools to guide specialists in their therapeutic decision-making. Considers emerging antiviral treatments, including the use of gene therapy, antisense, ribozymes, and immunomodulatory approaches. |
Contents
1 Emerging and Reemerging Viral Pathogens | 1 |
The Virus the Disease and Its Control | 32 |
3 Respiratory Syncytial Virus | 73 |
4 Rhinovirus | 111 |
5 Herpes Simplex Virus | 132 |
6 VaricellaZoster Virus | 154 |
7 VaricellaZoster Virus | 182 |
8 Hepatitis A Virus | 207 |
Epidemiology Pathogenesis and Principles of Antiretroviral Therapy | 303 |
12 Diagnosis and Management of HIV Infection Using Immunoassays and Molecular Technologies | 358 |
13 NucleosideNucleotide Inhibitors of HIV Reverse Transcriptase | 405 |
14 NonNucleoside Inhibitors of HIV Reverse Transcriptase | 424 |
15 HIV Protease Inhibitors | 440 |
16 Emerging Therapies for HIV Infection | 470 |
Diagnosis Pathophysiology and Treatment | 498 |
Pathogenesis and Treatment | 526 |
9 Hepatitis B Virus | 222 |
10 Hepatitis C Virus | 237 |
19 The Human Herpesviruses HHV6 HHV7 and HHV8 | 555 |
| 590 | |
Other editions - View all
Viral Infections and Treatment Helga Rübsamen-Waigmann,Karl Deres,Guy Hewlett,Reinhold Welker Limited preview - 2003 |
Viral Infections and Treatment Helga Rübsamen-Waigmann,Karl Deres,Guy Hewlett,Reinhold Welker Limited preview - 2003 |
Common terms and phrases
acid activity acute acyclovir addition adults agents AIDS antibodies antigen antiretroviral antiviral assay associated binding blood Cancer cause cells chronic hepatitis Clin clinical combination compounds containing currently cytomegalovirus detection disease dose drug early effects efficacy expression gene genital herpes genome hepatitis herpes HIV infection host human immunodeficiency virus immune important increased indicated individuals induce influenza inhibition inhibitors initial interferon isolates lesions levels liver marrow molecular mutations Nature occur oral patients polymerase positive prevention primary production protease protein recent receptor reduced region replication reported resistance respiratory syncytial virus response reverse transcriptase rhinovirus ribavirin risk sequence severe showed shown specific strains structure studies subtypes suggest symptoms therapy transmission transplantation treatment trials vaccine viral Virol virological virus infection viruses vitro weeks Western blot zoster